Improving healthcare infrastructure across the region and a large treatment-naïve patient population makes the Middle East and North Africa (MENA) an increasingly attractive destination for drug trials says ClinTec CEO Rabinder Buttar.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
